phosphorus has been researched along with bromocriptine in 6 studies
Studies (phosphorus) | Trials (phosphorus) | Recent Studies (post-2010) (phosphorus) | Studies (bromocriptine) | Trials (bromocriptine) | Recent Studies (post-2010) (bromocriptine) |
---|---|---|---|---|---|
48,074 | 1,126 | 17,139 | 7,121 | 727 | 499 |
Protein | Taxonomy | phosphorus (IC50) | bromocriptine (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.532 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 2.4 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 2.4996 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.015 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0016 | |
Androgen receptor | Rattus norvegicus (Norway rat) | 2.281 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.035 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.52 | |
D | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0056 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
D(1A) dopamine receptor | Homo sapiens (human) | 2.889 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.514 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.03 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.036 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.532 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.0056 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.0006 | |
5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.0083 | |
5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 0.022 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0279 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (83.33) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belforte, L; Camanni, F; Chiodini, PG; Liuzzi, A; Massara, F; Molinatti, GM; Müller, EE; Silvestrini, F | 1 |
Foley, S; James, MF; Makeen, AM; Robinson, CJ; Stevens, J | 1 |
Giacovazzo, M; Martelletti, P; Romiti, A | 1 |
Bijlsma, JW; Bosch, R; Croughs, RJ; Duursma, SA; Nortier, JW; Thijssen, JH | 1 |
Delvin, EE; Glorieux, FH; Mehta, AE; Pettifor, JM | 1 |
Dluhy, RG; Solomon, CG | 1 |
6 other study(ies) available for phosphorus and bromocriptine
Article | Year |
---|---|
Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.
Topics: Acromegaly; Adult; Blood Glucose; Bromocriptine; Calcium; Drug Evaluation; Ergolines; Female; Glycosuria; Growth Hormone; Humans; Hydroxyproline; Insulin; Insulin Secretion; Male; Middle Aged; Phosphates; Phosphorus; Prolactin; Thyrotropin-Releasing Hormone; Time Factors | 1977 |
Effects of prolactin and bromocriptine upon calcium and phosphorus absorption in lactating and non-lactating rats [proceedings].
Topics: Animals; Bromocriptine; Calcium; Female; Intestinal Absorption; Lactation; Phosphorus; Pregnancy; Prolactin; Rats | 1977 |
[Behavior of blood somatotropin and phosphorus levels after administration of 2-bromo-alpha-ergocryptine].
Topics: Acromegaly; Bromocriptine; Growth Hormone; Humans; Male; Phosphorus | 1978 |
Changes in bone metabolism during treatment of acromegaly.
Topics: 25-Hydroxyvitamin D3 1-alpha-Hydroxylase; Acid Phosphatase; Acromegaly; Adult; Aged; Bone and Bones; Bromocriptine; Calcitriol; Calcium; Creatinine; Female; Growth Hormone; Humans; Hydroxyproline; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prolactin | 1983 |
Effects of hyperprolactinemia on calciotropic hormones.
Topics: Adenoma; Adult; Alkaline Phosphatase; Bromocriptine; Calcium; Dihydroxycholecalciferols; Female; Humans; Kidney; Middle Aged; Parathyroid Hormone; Phosphorus; Prolactin | 1980 |
Paraneoplastic endocrine syndromes.
Topics: Acromegaly; Adrenocorticotropic Hormone; Aminoglutethimide; Bromocriptine; Calcitonin; Cushing Syndrome; Diazoxide; Diphosphonates; Estrogens; Fluid Therapy; Hemangiopericytoma; Humans; Hypercalcemia; Hyperthyroidism; Hypoglycemia; Inappropriate ADH Syndrome; Ketoconazole; Mifepristone; Mineralocorticoids; Mitotane; Octreotide; Osteomalacia; Pamidronate; Paraneoplastic Endocrine Syndromes; Phosphorus; Plicamycin; Propylthiouracil; Saline Solution, Hypertonic; Somatostatin; Thyroid Neoplasms | 1994 |